Sunovion Pharmaceuticals (India) Private Limited
About Sunovion Pharmaceuticals (India) Private Limited
Data last updated:
Sunovion Pharmaceuticals (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC340493. Its GSTIN is 09ABDCS7570A1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Aashirwaad Chaurasia and Abhay Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Survey No. 49 S/3 Yashodham Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.23 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹3.08 Lakh (net margin 2.5%) and EBITDA of ₹3.48 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 83% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
Company details
Contact details
Sunovion Pharmaceuticals (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressSurvey No. 49 S/3 Yashodham Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunovion Pharmaceuticals (India) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Sunovion Pharmaceuticals (India) Private Limited
FY 2026 filings availableSunovion Pharmaceuticals (India) Private Limited reported revenue of ₹1.23 Cr (up 67% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 83% over five years, including 67% growth in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.23 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.48 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Sunovion Pharmaceuticals (India) Private Limited
Sunovion Pharmaceuticals (India) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aashirwaad Chaurasia | Director | 02 Jul 2021 | 5 Years 4 Months | Current |
| Abhay Pratap Singh | Director | 02 Jul 2021 | 5 Years 4 Months | Current |
| Reena Arya | Director | 10 Jun 2020 | 6 Years 5 Months | Current |
Auditor
Sunovion Pharmaceuticals (India) Private Limited is audited by AGRAWAL SACHIN & CO. for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL SACHIN & CO. | FY 2026 | 0019035C |
Shareholding
The shareholding of Sunovion Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunovion Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunovion Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sunovion Pharmaceuticals (India) Private Limited has a workforce of 10 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 10 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
GST
Sunovion Pharmaceuticals (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09ABDCS7570A1ZC | Uttar Pradesh | Active | 05 Aug 2020 |
To see the full GST registrations and return filing status of Sunovion Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Sunovion Pharmaceuticals (India) Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Aashirwaad Chaurasia was appointed as Director on 02 Jul 2021.
Frequently asked questions
Sunovion Pharmaceuticals (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 10 June 2020 (6+ years old) and is registered under CIN U51909MH2020PTC340493.
Sunovion Pharmaceuticals (India) has 3 current directors:
- Aashirwaad Chaurasia - Director
- Abhay Pratap Singh - Director
- Reena Arya - Director
The latest financial statements of Sunovion Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sunovion Pharmaceuticals (India) is 09ABDCS7570A1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sunovion Pharmaceuticals (India) is U51909MH2020PTC340493. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunovion Pharmaceuticals (India) was incorporated on 10 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Aashirwaad Chaurasia was appointed as Director on 02 Jul 2021. Abhay Pratap Singh was appointed as Director on 02 Jul 2021. Arati Dwivedi ceased to be Director on 02 Jul 2021. Sunovion Pharmaceuticals (India) has 4 board changes on record in total.
The registered office of Sunovion Pharmaceuticals (India) is at Survey No. 49 S3 Yashodham Goregaon E, Mumbai, Maharashtra, India – 400063.
Sunovion Pharmaceuticals (India) operates in the trading industry, in the specialty segment.
Sunovion Pharmaceuticals (India) can be reached at its registered office: Survey No. 49 S3 Yashodham Goregaon E, Mumbai, Maharashtra, India – 400063.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
